Is 5-MAPB Legal in Kentucky? (2026)

Instrument

statute

Source

https://apps.legislature.ky.gov/law/kar/titles/902/055/015/9121/

Retrieved

2026-06-19

Fingerprint

584940202b9d4357

**Schedule mechanism — 902 KAR 55:015 § 1:** "Each substance that is scheduled or designated as a Schedule I controlled substance under 21 C.F.R. 1308.11 … shall be scheduled or designated at the state level as a Schedule I controlled substance." (Kentucky lists no individual state tryptamines; the question collapses to the federal list, which does not name 4-HO-MET.)
— 902 KAR 55:015 § 1: https://apps.legislature.ky.gov/law/kar/titles/902/055/015/9121/
**Analog act — KRS 218A.010(7):** "'Controlled substance analogue,' except as provided in paragraph (b) … means a substance: 1. The chemical structure of which is substantially similar to the structure of a controlled substance in Schedule I or II; and 2. Which has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than … a controlled substance in Schedule I or II; or 3. With respect to a particular person, which such person represents or intends to have [such effect] …" And **KRS 218A.010(6):** "'Controlled substance' means … a drug, substance, or immediate precursor in Schedules I through V and includes a controlled substance analogue."
— KRS 218A.010(6)–(7); via labeled Justia mirror, cross-checked against current FindLaw (identical): https://law.justia.com/codes/kentucky/2014/chapter-218a/section-218a.010/

Instrument

Definitions for chapter -- 'controlled substance' includes a controlled substance analogue; definition of controlled substance analogue

Source

https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=54047

Retrieved

2026-07-20

Fingerprint

9e787874586183ca

(8) 'Controlled substance' means methamphetamine, or a drug, substance, or immediate precursor in Schedules I through V and includes a controlled substance analogue; (9)(a) 'Controlled substance analogue,' except as provided in paragraph (b) of this subsection, means a substance: 1. The chemical structure of which is substantially similar to the structure of a controlled substance in Schedule I or II; and 2. Which has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II; or 3. With respect to a particular person, which such person represents or intends to have a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to or greater than the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance in Schedule I or II. (b) Such term does not include: 1. Any substance for which there is an approved new drug application; 2. With respect to a particular person, any substance if an exemption is in effect for investigational use for that person pursuant to federal law to the extent conduct with respect to such substance is pursuant to such exemption; or 3. Any substance to the extent not intended for human consumption before the exemption described in subparagraph 2. of this paragraph takes effect with respect to that substance;